Multiple Sclerosis Highlights From EAN 2022 Multiple Sclerosis Highlights From EAN 2022

Key presentations in multiple sclerosis at EAN 2022 included updated EAN-ECTRIMS treatment guidelines, prognostic biomarker findings, and data on BTK inhibitors in RRMS, as reported by Prof Jens Kuhle.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery ReCAP Source Type: news